HJV Hemochromatosis, Iron Overload, and Hypogonadism in a Brazilian Man: Treatment with Phlebotomy and Deferasirox

Publisher： Karger

E-ISSN： 1421-9662|124|4|204-205

ISSN： 0001-5792

Source： Acta Haematologica, Vol.124, Iss.4, 2010-11, pp. : 204-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Deferasirox (Exjade®) for the Treatment of Iron Overload

By  

Acta Haematologica, Vol. 122, Iss. 2-3, 2009-11 ,pp. : 165-173

Karger

Access to resources Recommend Favorite

Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-01 ,pp. : 219-221

Karger

Access to resources Recommend Favorite

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of Transfusion Dependency Following Deferasirox Treatment of Iron Overload in a Woman with Myelofibrosis and Spherocytosis - a Case Report

By  

Oncology Research and Treatment, Vol. 36, Iss. 4, 2013-03 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 113-118

Karger

Access to resources Recommend Favorite